PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Feb-2026 Exdensur (depemokimab) approved by the European Commission for severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps GSK
17-Feb-2026 Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression Businesswire
17-Feb-2026 Pumas 2.8 Sets a New Standard for Clinical Pharmacology and Pharmacometrics Technology with Embedded AI and Next Generation Estimation PumasAI
17-Feb-2026 Tolion Health AI Forms Scientific Advisory Board with Leading Experts in Alzheimer’s, Brain Health, and Artificial Intelligence Businesswire
17-Feb-2026 NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscia’s Platform Proscia
17-Feb-2026 Cambridge Cognition partners with Ivory to scale early cognitive screening with CANTAB Pathway™ in India Cambridge Cognition
17-Feb-2026 Nuclera and leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins Businesswire
17-Feb-2026 Medica and Axon Diagnostics Merge to Enhance Diagnostic Services in the UK Medica and Axon Diagnostics
17-Feb-2026 Cambridge Cognition partners with Ivory to scale early cognitive screening with CANTAB Pathway™ in India Cambridge Cognition
17-Feb-2026 Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer Nucleome Therapeutics
17-Feb-2026 Uniphar | Clinical merges with BMclinical to strengthen global clinical trial services Uniphar | Clinical
17-Feb-2026 HORIBA to Build a New Global Headquarters HORIBA
17-Feb-2026 FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference FundaMental Pharma
17-Feb-2026 Government determined to destroy hospitality with unjustifiable vape ban IEA
17-Feb-2026 LEX Diagnostics Receives FDA 510(k) Clearance and CLIA Waiver for LEX VELO System LEX Diagnostics
17-Feb-2026 MEDHOST Announces Strategic Partnership with RevSpring to Enhance Patient Engagement and Financial Experience Solutions  ACCESS Newswire
17-Feb-2026 FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference FundaMental Pharma
17-Feb-2026 Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin® at ESGO 2026 Oncoinvent
17-Feb-2026 RoukenBio and AVS Bio Announce Strategic Partnership to Integrate Design-Focused Antibody Discovery and Optimisation with Mechanism-Driven Functional Characterisation RoukenBio
17-Feb-2026 Newron Secures Up to EUR 38 Million to Advance Phase III Evenamide Program Newron